Clinical Trial Update: Efficacy Assessment of Lenvatinib Associated with Pembrolizumab in Metastatic Endometrial Cancer: a French Multicentric Retrospective Early Access Program-based Study

View source ↗

Summary

This document reports on a retrospective French multicenter study assessing the efficacy of combining lenvatinib with pembrolizumab in metastatic endometrial ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Lenvatinib (lenvatinib)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: Metastatic Endometrial Cancer | Status: COMPLETED